Disposable Hemostatic Agents Market By Product Type (Thrombin Based, Gelatin-Based, Collagen-Based, Oxidized Regenerated Cellulose Based, Combination, Fibrin Sealants, and Others), Application (Orthopedic, General, Neurological, Cardiovascular, Digestive and Other), End Users, and Geography – Global Forecast up to 2026
Hemostatic agents are used to reduce the bleeding from a body vessel. In the field of hemostatic agents, disposable hemostatic agents are emerging technology. Disposable hemostatic agents have a vital role in improving hemostasis by enhancing fibrin formation. Especially in endoscopic procedures, disposable hemostatic agents are increasingly used. Disposable hemostatic agents have various applications in the number of treatments. The Disposable Hemostatic Agents Market is estimated to grow at the rate of 5.3% CAGR by 2026. There is a high chance of hemorrhage, increasing the demand for disposable hemostatic agents, and the rising importance of blood management, projected to drive the global market. In addition, innovations such as robot-assisted surgery in surgical procedures and the increasing elderly population are likely to fuel the demand for disposable hemostatic agents. However, the high costs incurred in the surgical procedures and lack of reimbursements for surgical products may restrict the market growth.
Disposable Hemostatic Agents Market based on Product Type
The applications of the disposable hemostatic agents are orthopedic, general, neurological, cardiovascular, digestive, and other. Among them, disposable hemostatic agents are majorly applicable in cardiovascular surgery. The cardiovascular surgery segment leads the market due to increased cardiovascular problems due to shifts in public and food habits, fueling the segment's growth.
Based on the end-users, the disposable hemostatic agents market is divided into ambulatory surgical centers, specialty clinics, and hospitals. The hospital's segment holds a significant share of the market. This is due to the increasing number of hospitals well equipped with advanced technology and the increasing number of patients visiting hospitals for different surgeries, boosting the market growth in this segment.
In terms of the geographical market of disposable hemostatic agents, the North American region substantially contributes to market share growth. The factors such as the robust surgical procedures volumes lead to the surging demand for disposable hemostatic agents. Moreover, the well-advanced hospital facilities with high adoption of technologically advanced products are also responsible for the market growth in the region.
Few factors that are expected to compel the global market growth for disposable hemostatic agents are the growth in the number of surgical procedures performed globally and the rising population of elderly patients. Since the wounds and injuries of elderly patients take a lot of time to heal, the requirement for proper care and bleeding management systems is essential, carried out by disposable hemostatic agents.
Key competitors operating in the disposable hemostatic agents market include The Medicines Company, C. R. Bard Inc., Baxter International Inc., Ethicon Inc., Pfizer Inc., Vascular Solutions Inc., Anika Therapeutics Inc., Advanced Medical Solutions, Integra LifeSciences, and Equimedical.
Henceforth, surgeons consider the disposable hemostatic agents are of critical importance during all surgical procedures. A key priority of perfect surgical technique is curbing blood loss, and nowadays, surgeons have a wide variety of agents to assist the surgeons in this attempt.
Disposable Hemostatic Agents Market based on Product Type
- Thrombin Based Hemostatics
- Gelatin Based Hemostatics
- Collagen Based Hemostatics
- Oxidized Regenerated Cellulose Based Hemostatics
- Combination Hemostatics
- Fibrin Sealants
- Others
- Orthopedic surgery
- General surgery
- Neurological surgery
- Cardiovascular surgery
- Digestive surgery
- Other surgeries
- Ambulatory surgical centers
- Specialty clinics
- Hospitals
- North America
- Europe
- Asia Pacific
- Rest of the World
The applications of the disposable hemostatic agents are orthopedic, general, neurological, cardiovascular, digestive, and other. Among them, disposable hemostatic agents are majorly applicable in cardiovascular surgery. The cardiovascular surgery segment leads the market due to increased cardiovascular problems due to shifts in public and food habits, fueling the segment's growth.
Based on the end-users, the disposable hemostatic agents market is divided into ambulatory surgical centers, specialty clinics, and hospitals. The hospital's segment holds a significant share of the market. This is due to the increasing number of hospitals well equipped with advanced technology and the increasing number of patients visiting hospitals for different surgeries, boosting the market growth in this segment.
In terms of the geographical market of disposable hemostatic agents, the North American region substantially contributes to market share growth. The factors such as the robust surgical procedures volumes lead to the surging demand for disposable hemostatic agents. Moreover, the well-advanced hospital facilities with high adoption of technologically advanced products are also responsible for the market growth in the region.
Few factors that are expected to compel the global market growth for disposable hemostatic agents are the growth in the number of surgical procedures performed globally and the rising population of elderly patients. Since the wounds and injuries of elderly patients take a lot of time to heal, the requirement for proper care and bleeding management systems is essential, carried out by disposable hemostatic agents.
Key competitors operating in the disposable hemostatic agents market include The Medicines Company, C. R. Bard Inc., Baxter International Inc., Ethicon Inc., Pfizer Inc., Vascular Solutions Inc., Anika Therapeutics Inc., Advanced Medical Solutions, Integra LifeSciences, and Equimedical.
Henceforth, surgeons consider the disposable hemostatic agents are of critical importance during all surgical procedures. A key priority of perfect surgical technique is curbing blood loss, and nowadays, surgeons have a wide variety of agents to assist the surgeons in this attempt.
- This research provides complete information about the disposable hemostatic agents market and the analysis of both qualitative and quantitative.
- The report offers an outline and prediction of the market based on product type, application, end-users, and geographical regions.
- Further depicts the market size and projections for the entire disposable hemostatic agents market in terms of four key regions: North America, Europe, Asia-Pacific, and the rest of the world.
- The significant market vendors present in the disposable hemostatic agents market are profiled in the research and their SWOT analysis and market strategies.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. PRODUCT TYPE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Thrombin Based Hemostatics
5.3. Gelatin Based Hemostatics
5.4. Collagen Based Hemostatics
5.5. Oxidized Regenerated Cellulose Based Hemostatics
5.6. Combination Hemostatics
5.7. Fibrin Sealants
5.8. Others
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Orthopedic surgery
6.3. General surgery
6.4. Neurological surgery
6.5. Cardiovascular surgery
6.6. Digestive surgery
6.7. Other surgeries
7. END-USERS: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Ambulatory surgical centers
7.3. Specialty clinics
7.4. Hospitals
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. The Medicines Company
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. C. R. Bard Inc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Baxter International Inc.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Ethicon Inc.
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Pfizer Inc.
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Vascular Solutions Inc.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Anika Therapeutics Inc.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Advanced Medical Solutions
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Integra LifeSciences
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Equimedical
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. PRODUCT TYPE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Thrombin Based Hemostatics
5.3. Gelatin Based Hemostatics
5.4. Collagen Based Hemostatics
5.5. Oxidized Regenerated Cellulose Based Hemostatics
5.6. Combination Hemostatics
5.7. Fibrin Sealants
5.8. Others
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Orthopedic surgery
6.3. General surgery
6.4. Neurological surgery
6.5. Cardiovascular surgery
6.6. Digestive surgery
6.7. Other surgeries
7. END-USERS: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Ambulatory surgical centers
7.3. Specialty clinics
7.4. Hospitals
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. The Medicines Company
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. C. R. Bard Inc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Baxter International Inc.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Ethicon Inc.
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Pfizer Inc.
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Vascular Solutions Inc.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Anika Therapeutics Inc.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Advanced Medical Solutions
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Integra LifeSciences
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Equimedical
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
LIST OF TABLES
TABLE 1. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR THROMBIN BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR GELATIN BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR COLLAGEN-BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR COMBINATION HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR FIBRIN SEALANTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR ORTHOPEDIC SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR GENERAL SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR NEUROLOGICAL SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR CARDIOVASCULAR SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR DIGESTIVE SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OTHER SURGERIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 17. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 18. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR SPECIALTY CLINICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 19. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 20. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 21. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 22. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 23. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 24. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 25. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 26. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 27. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 28. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 29. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 30. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 31. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 32. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 33. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, END-USERS, 2020-2026 (USD BILLION)
TABLE 34. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 35. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 36. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 37. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 38. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 39. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 40. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 41. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 42. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 43. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 44. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 45. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 46. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 47. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 48. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 49. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 50. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 51. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 52. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 53. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 54. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 55. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 56. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 57. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 58. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 59. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 60. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 61. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 62. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 63. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 64. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 65. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 66. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 67. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 68. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 69. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 70. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 71. THE MEDICINES COMPANY: FINANCIALS
TABLE 72. THE MEDICINES COMPANY: PRODUCTS & SERVICES
TABLE 73. THE MEDICINES COMPANY: RECENT DEVELOPMENTS
TABLE 74. C. R. BARD INC: FINANCIALS
TABLE 75. C. R. BARD INC: PRODUCTS & SERVICES
TABLE 76. C. R. BARD INC: RECENT DEVELOPMENTS
TABLE 77. BAXTER INTERNATIONAL INC: FINANCIALS
TABLE 78. BAXTER INTERNATIONAL INC: PRODUCTS & SERVICES
TABLE 79. BAXTER INTERNATIONAL INC: RECENT DEVELOPMENTS
TABLE 80. ETHICON INC: FINANCIALS
TABLE 81. ETHICON INC: PRODUCTS & SERVICES
TABLE 82. ETHICON INC: RECENT DEVELOPMENTS
TABLE 83. PFIZER INC: FINANCIALS
TABLE 84. PFIZER INC: PRODUCTS & SERVICES
TABLE 85. PFIZER INC: RECENT DEVELOPMENTS
TABLE 86. VASCULAR SOLUTIONS INC: FINANCIALS
TABLE 87. VASCULAR SOLUTIONS INC: PRODUCTS & SERVICES
TABLE 88. VASCULAR SOLUTIONS INC: RECENT DEVELOPMENTS
TABLE 89. ANIKA THERAPEUTICS INC: FINANCIALS
TABLE 90. ANIKA THERAPEUTICS INC: PRODUCTS & SERVICES
TABLE 91. ANIKA THERAPEUTICS INC: RECENT DEVELOPMENTS
TABLE 92. ADVANCED MEDICAL SOLUTIONS: FINANCIALS
TABLE 93. ADVANCED MEDICAL SOLUTIONS: PRODUCTS & SERVICES
TABLE 94. ADVANCED MEDICAL SOLUTIONS: RECENT DEVELOPMENTS
TABLE 95. INTEGRA LIFESCIENCES: FINANCIALS
TABLE 96. INTEGRA LIFESCIENCES: PRODUCTS & SERVICES
TABLE 97. INTEGRA LIFESCIENCES: RECENT DEVELOPMENTS
TABLE 98. EQUIMEDICAL: FINANCIALS
TABLE 99. EQUIMEDICAL: PRODUCTS & SERVICES
TABLE 100. EQUIMEDICAL: RECENT DEVELOPMENTS
TABLE 1. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR THROMBIN BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR GELATIN BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR COLLAGEN-BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR COMBINATION HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR FIBRIN SEALANTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR ORTHOPEDIC SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR GENERAL SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR NEUROLOGICAL SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR CARDIOVASCULAR SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR DIGESTIVE SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OTHER SURGERIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 17. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 18. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR SPECIALTY CLINICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 19. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 20. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 21. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 22. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 23. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 24. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 25. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 26. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 27. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 28. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 29. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 30. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 31. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 32. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 33. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, END-USERS, 2020-2026 (USD BILLION)
TABLE 34. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 35. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 36. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 37. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 38. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 39. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 40. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 41. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 42. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 43. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 44. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 45. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 46. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 47. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 48. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 49. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 50. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 51. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 52. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 53. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 54. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 55. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 56. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 57. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 58. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 59. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 60. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 61. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 62. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 63. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 64. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 65. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 66. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 67. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 68. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
TABLE 69. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 70. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
TABLE 71. THE MEDICINES COMPANY: FINANCIALS
TABLE 72. THE MEDICINES COMPANY: PRODUCTS & SERVICES
TABLE 73. THE MEDICINES COMPANY: RECENT DEVELOPMENTS
TABLE 74. C. R. BARD INC: FINANCIALS
TABLE 75. C. R. BARD INC: PRODUCTS & SERVICES
TABLE 76. C. R. BARD INC: RECENT DEVELOPMENTS
TABLE 77. BAXTER INTERNATIONAL INC: FINANCIALS
TABLE 78. BAXTER INTERNATIONAL INC: PRODUCTS & SERVICES
TABLE 79. BAXTER INTERNATIONAL INC: RECENT DEVELOPMENTS
TABLE 80. ETHICON INC: FINANCIALS
TABLE 81. ETHICON INC: PRODUCTS & SERVICES
TABLE 82. ETHICON INC: RECENT DEVELOPMENTS
TABLE 83. PFIZER INC: FINANCIALS
TABLE 84. PFIZER INC: PRODUCTS & SERVICES
TABLE 85. PFIZER INC: RECENT DEVELOPMENTS
TABLE 86. VASCULAR SOLUTIONS INC: FINANCIALS
TABLE 87. VASCULAR SOLUTIONS INC: PRODUCTS & SERVICES
TABLE 88. VASCULAR SOLUTIONS INC: RECENT DEVELOPMENTS
TABLE 89. ANIKA THERAPEUTICS INC: FINANCIALS
TABLE 90. ANIKA THERAPEUTICS INC: PRODUCTS & SERVICES
TABLE 91. ANIKA THERAPEUTICS INC: RECENT DEVELOPMENTS
TABLE 92. ADVANCED MEDICAL SOLUTIONS: FINANCIALS
TABLE 93. ADVANCED MEDICAL SOLUTIONS: PRODUCTS & SERVICES
TABLE 94. ADVANCED MEDICAL SOLUTIONS: RECENT DEVELOPMENTS
TABLE 95. INTEGRA LIFESCIENCES: FINANCIALS
TABLE 96. INTEGRA LIFESCIENCES: PRODUCTS & SERVICES
TABLE 97. INTEGRA LIFESCIENCES: RECENT DEVELOPMENTS
TABLE 98. EQUIMEDICAL: FINANCIALS
TABLE 99. EQUIMEDICAL: PRODUCTS & SERVICES
TABLE 100. EQUIMEDICAL: RECENT DEVELOPMENTS
LIST OF FIGURES
CHART. 1. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR THROMBIN BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR GELATIN BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR COLLAGEN-BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR COMBINATION HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR FIBRIN SEALANTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 8. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR ORTHOPEDIC SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR GENERAL SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 12. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR NEUROLOGICAL SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR CARDIOVASCULAR SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR DIGESTIVE SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OTHER SURGERIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 17. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 18. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR SPECIALTY CLINICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 19. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 20. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 21. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 22. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 23. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 24. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 25. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 26. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 27. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 28. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 29. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 30. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 31. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 32. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 33. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, END-USERS, 2020-2026 (USD BILLION)
CHART. 34. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 35. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 36. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 37. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 38. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 39. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 40. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 41. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 42. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 43. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 44. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 45. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 46. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 47. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 48. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 49. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 50. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 51. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 52. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 53. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 54. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 55. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 56. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 57. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 58. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 59. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 60. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 61. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 62. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 63. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 64. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 65. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 66. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 67. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 68. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 69. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 70. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 1. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR THROMBIN BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR GELATIN BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR COLLAGEN-BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR COMBINATION HEMOSTATICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR FIBRIN SEALANTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 8. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR ORTHOPEDIC SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR GENERAL SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 12. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR NEUROLOGICAL SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR CARDIOVASCULAR SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR DIGESTIVE SURGERY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR OTHER SURGERIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 17. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 18. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR SPECIALTY CLINICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 19. GLOBAL DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 20. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 21. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 22. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 23. NORTH AMERICA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 24. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 25. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 26. U.S DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 27. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 28. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 29. CANADA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 30. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 31. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 32. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 33. EUROPE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, END-USERS, 2020-2026 (USD BILLION)
CHART. 34. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 35. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 36. GERMANY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 37. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 38. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 39. U.K DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 40. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 41. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 42. FRANCE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 43. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 44. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 45. ITALY DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 46. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 47. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 48. SPAIN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 49. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 50. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 51. ROE DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 52. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 53. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 54. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 55. ASIA PACIFIC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 56. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 57. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 58. CHINA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 59. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 60. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 61. INDIA DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 62. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 63. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 64. JAPAN DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 65. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 66. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 67. REST OF APAC DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)
CHART. 68. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY PRODUCT TYPE, 2020-2026 (USD BILLION)
CHART. 69. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 70. REST OF WORLD DISPOSABLE HEMOSTATIC AGENTS MARKET VALUE, BY END-USERS, 2020-2026 (USD BILLION)